Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This is a **combination oral care agent** composed of stannous fluoride and sodium tripolyphosphate, formulated primarily for use in dentifrices (toothpastes). **Stannous fluoride** is an anti-caries and antimicrobial agent effective at preventing dental caries, reducing the viability of the oral biofilm, enhancing remineralization of hydroxyapatite in tooth enamel, reducing tooth hypersensitivity, and fighting both plaque and gingivitis[1][2][3][4][6]. **Sodium tripolyphosphate** is a polyphosphate frequently included in toothpaste as a stain control and tartar-prevention agent, chelating calcium to inhibit tartar/calculus formation and helping stabilize stannous fluoride[3][5]. This combination leverages the synergistic effects: stannous fluoride provides strong anti-caries and anti-gingivitis action, while sodium tripolyphosphate mitigates the tendency of stannous fluoride to cause staining and boosts stain removal/tartar prevention[5]. Advances in formulation have enabled stable preparations that maintain both efficacy and esthetics[3][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on stannous fluoride + sodium tripolyphosphate.